FDA Panel: Too early to pull textured breast implants over cancer risk, need more data
FDA Panel: Too early to pull textured breast implants over cancer risk, need more data
Published in Breast Implant-Associated Anaplastic Large Cell Lymphoma BIA-ALCL, Breast Implants and USA
More from Breast Implant-Associated Anaplastic Large Cell Lymphoma BIA-ALCLMore posts in Breast Implant-Associated Anaplastic Large Cell Lymphoma BIA-ALCL »
- EU – SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
- SCHEER Safety of breast implants WG – minutes of 4 November 2019 meeting
- EU – Minutes of the 24 July 2019 SCHEER Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
- TGA – Australian regulatory action on breast implants and breast tissue expanders
- The FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from the Market: FDA Safety Communication
More from Breast ImplantsMore posts in Breast Implants »
- EU – SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
- SCHEER Safety of breast implants WG – minutes of 4 November 2019 meeting
- US FDA Draft Guidance – Breast Implants – Certain Labeling Recommendations to Improve Patient Communication
- EU – Minutes of the 24 July 2019 SCHEER Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
- TGA – Current status of breast implant products in Australia
More from USAMore posts in USA »
- EU – Team-NB Position Paper on Documentation Requirements for Drug Device Combination Products Falling in the Scope of Article 117 of MDR 2017/745.
- US – AAMI Offers Free Standards and Resources to Help Fight Coronavirus
- US – FDA Issues Immediately in Effect Guidance on Ventilators During COVID-19
- US – Ventilator Supply Mitigation Strategies – Letter to Health Care Providers
- US – Update on the Ethylene Oxide Sterilization Master File Pilot Program
Be First to Comment